A Study to Assess the Effect of Plazomicin on the Pharmacokinetics of Metformin
Completed · Phase 1
Conditions studied: Healthy Volunteers
In brief
This is a single-center, Phase 1, open label, randomized, two-sequence, two-period, crossover study to evaluate the drug-drug interaction potential between plazomicin and metformin in healthy subjects.
Key facts
- Study ID
- NCT03270553
- Run by
- Achaogen, Inc.
- People needed
- 16
- Starts
- 2017-08-31
- Expected to finish
- 2017-10-07
- Last updated by the study team
- 2017-10-11
Who can join
Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Clinical Site — Lincoln, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.